Cargando…
Tumour Cells Expressing Single VEGF Isoforms Display Distinct Growth, Survival and Migration Characteristics
Vascular endothelial growth factor-A (VEGF) is produced by most cancer cells as multiple isoforms, which display distinct biological activities. VEGF plays an undisputed role in tumour growth, vascularisation and metastasis; nevertheless the functions of individual isoforms in these processes remain...
Autores principales: | Kanthou, Chryso, Dachs, Gabi U., Lefley, Diane V., Steele, Andrew J., Coralli-Foxon, Claudia, Harris, Sheila, Greco, Olga, Dos Santos, Sofia A., Reyes-Aldasoro, Constantino C., English, William R., Tozer, Gillian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131915/ https://www.ncbi.nlm.nih.gov/pubmed/25119572 http://dx.doi.org/10.1371/journal.pone.0104015 |
Ejemplares similares
-
Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale
por: Harris, Sheila, et al.
Publicado: (2012) -
Anti-vascular agent Combretastatin A-4-P modulates Hypoxia Inducible Factor-1 and gene expression
por: Dachs, Gabi U, et al.
Publicado: (2006) -
The protective role of sphingosine-1-phosphate against the action of the vascular disrupting agent combretastatin A-4 3-O-phosphate
por: Shepherd, Joanna, et al.
Publicado: (2017) -
An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate
por: Williams, L J, et al.
Publicado: (2014) -
Gene delivery to hypoxic cells in vitro
por: Dachs, G U, et al.
Publicado: (2000)